Sigyn Therapeutics, Inc. (SIGY) › Weighted Average Diluted SharesSigyn Therapeutics, Inc. (SIGY) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2014-12-31: 27.95M2015-12-31: 30.99M2017-12-31: 47.09M2018-12-31: 65.07M2019-12-31: 81.27M2020-12-31: 7.35M2021-12-31: 36.40M2022-12-31: 934.9K2023-12-31: 1.10M2024-12-31: 1.33M1.33M2014-12-31Weighted Average Diluted Shares (shares)2024-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2024-12-311.33M+21.1%2025-04-15From 2024-01-012023-12-311.10M+17.7%2025-04-15From 2023-01-012022-12-31934.9K-97.4%2024-02-20From 2022-01-012021-12-3136.40M+395.1%2023-03-31From 2021-01-012020-12-317.35M-91.0%2022-03-21From 2020-01-012019-12-3181.27M+24.9%2020-03-30From 2019-01-012018-12-3165.07M+38.2%2020-03-30From 2018-01-012017-12-3147.09M—2019-04-01From 2017-01-012015-12-3130.99M+10.9%2016-03-30From 2015-01-012014-12-3127.95M—2016-03-30From 2014-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)